Login

VC Firm investing in the lifesciences|Daniel Yadegar,Chief Medical Officer,Newpath Partners 00:10:00

Share On Facebook Share On Twitter

Daniel Yadegar is the Co-Founder and CMO of Newpath Management.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Rio2 Mining's Financing Strategy for Phoenix Gold Project
00:10:00
Jayne Hrdlicka Discusses a2 Milk Company’s Recent Results, Market Strategy, and Competitive Landscape | Jayne Hrdlicka, CEO , A2 Milk Company.
00:10:00
Maria Edsman, CEO of Bokusgruppen, on Growth, Strategy, and the Future of Reading | Maria Edsman, CEO, Bokusgruppen AB.
00:10:00
Interview with Giovanni Cravero, Head of Credit Governance at Telecom Italia S.p.A.
00:10:00
Metals Madagascar: Achieving Milestones and Pursuing Growth in Graphite and Lithium
00:10:00
Fund investing in customer-centric founders redefining everyday experiences|Jessica Peltz-Zatulove,Founding Partner,Hannah Grey
00:10:00
Bridget Sora on the Impact of ACP Conferences and Overcoming Impostor Syndrome
00:10:00
The 1867 Project: Why Canada Should Be Cherished, Not Cancelled|Mark Milke,Professor,University of Canterbury
00:10:00
Exploring Electronic Innovation and Market ShiftsExploring Electronic Innovation and Market Shifts | Samuli Seppälä, Founder, Verkkokauppa.com Oyj.
00:00:00
Glynn Wilson, CEO, TapImmune Inc
00:10:00
Sebastien Paré is the Chief Executive Officer of VIQ Solutions Inc.
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd

© 2017 - Neuhu+